PALVELLA THERAPEUTICS, INC. (PVLA) Corporate Subsidiaries
PALVELLA THERAPEUTICS, INC. (PVLA) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: PVLA
CIK: 1583648
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: NV
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerAlyson Filippone
Audit LocationPhiladelphia, Pennsylvania, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-14 | 2026-10-12 | OWNERSHIP DOCUMENT | 0001104659-26-115916 | View SEC Doc Filr Page |
| 144 | 2026-10-13 | — | 144 Filing | 0001967940-26-000053 | View SEC Doc Filr Page |
| 4 | 2026-09-18 | 2026-09-16 | OWNERSHIP DOCUMENT | 0001104659-26-108930 | View SEC Doc Filr Page |
| 144 | 2026-09-16 | — | 144 Filing | 0001967940-26-000051 | View SEC Doc Filr Page |
| 4 | 2026-09-15 | 2026-09-11 | OWNERSHIP DOCUMENT | 0001104659-26-108022 | View SEC Doc Filr Page |
| 144 | 2026-09-11 | — | 144 Filing | 0001967940-26-000050 | View SEC Doc Filr Page |
| 4 | 2026-09-04 | 2026-09-02 | OWNERSHIP DOCUMENT | 0001104659-26-105494 | View SEC Doc Filr Page |
| 144 | 2026-09-02 | — | 144 Filing | 0001950047-26-008991 | View SEC Doc Filr Page |
| 4 | 2026-08-20 | 2026-08-19 | OWNERSHIP DOCUMENT | 0001104659-26-099222 | View SEC Doc Filr Page |
| 144 | 2026-08-19 | — | 144 Filing | 0001967940-26-000044 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001999371-26-018011 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0000921895-26-002180 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-10 | — | SCHEDULE 13G Filing | 0001137774-26-000180 | View SEC Doc Filr Page |
| S-8 | 2026-08-04 | — | FORM S-8 | 0001104659-26-090394 | View SEC Doc Filr Page |
| 10-Q | 2026-08-04 | 2026-06-30 | 10-Q | 0001193125-26-331574 | View SEC Doc Filr Page |
| 8-K | 2026-08-04 | 2026-08-04 | 8-K | 0001193125-26-331556 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-03 | — | SCHEDULE 13G Filing | 0000053417-26-000050 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-29 | — | SCHEDULE 13G Filing | 0002012383-26-002924 | View SEC Doc Filr Page |
| 4 | 2026-07-17 | 2026-07-15 | OWNERSHIP DOCUMENT | 0001104659-26-084620 | View SEC Doc Filr Page |
| 144 | 2026-07-15 | — | 144 Filing | 0001967940-26-000039 | View SEC Doc Filr Page |
| 8-K | 2026-07-14 | 2026-07-14 | 8-K | 0001193125-26-303307 | View SEC Doc Filr Page |
| 4 | 2026-07-01 | 2026-06-29 | OWNERSHIP DOCUMENT | 0001104659-26-079865 | View SEC Doc Filr Page |
| 3 | 2026-07-01 | 2026-06-29 | OWNERSHIP DOCUMENT | 0001104659-26-079863 | View SEC Doc Filr Page |
| 8-K | 2026-06-30 | 2026-06-29 | FORM 8-K | 0001104659-26-079087 | View SEC Doc Filr Page |
| 4 | 2026-06-22 | 2026-06-17 | OWNERSHIP DOCUMENT | 0001104659-26-076460 | View SEC Doc Filr Page |